{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:19:23Z","timestamp":1786979963897,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T00:00:00Z","timestamp":1551657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00296-019-04266-z","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T02:43:42Z","timestamp":1551667422000},"page":"723-727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Use of systemic glucocorticoids in patients with psoriatic arthritis by Argentinian and other Latin-American rheumatologists"],"prefix":"10.1007","volume":"39","author":[{"given":"Carolina","family":"Aimo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4739-4698","authenticated-orcid":false,"given":"Vanesa Laura","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0898-2224","authenticated-orcid":false,"given":"Gabriel","family":"Sequeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5704-6777","authenticated-orcid":false,"given":"Eduardo","family":"Kerzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,4]]},"reference":[{"key":"4266_CR1","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/B978-0-323-31696-5.00077-2","volume-title":"Kelley- Firestein. Textbook of Rheumatology","author":"O FitzGerald","year":"2017","unstructured":"FitzGerald O, Elmamoun M (2017) Psoriatic arthritis. In Kelley- Firestein. Textbook of Rheumatology. Edited by GS Firestein, SE Gabriel, IB McInnes, JR O\u2019Dell. 10th edn. Philadelphia. Elsevier. pp: 1285\u20131308","edition":"10"},{"issue":"5","key":"4266_CR2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jaad.2008.02.040","volume":"58","author":"A Gottlieb","year":"2008","unstructured":"Gottlieb A, Korman NJ, Gordon KB, Feldman SR, Lebwohl M, Koo JY, Van Voorhees AS, Elmets CA, Leonardi CL, Beutner KR, Bhushan R, Menter AJ (2008) Guidelines of care for the management of psoriasis and psoriatic arthritis: Sect. 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. Am Acad Dermatol 58(5):851\u2013864","journal-title":"Am Acad Dermatol"},{"issue":"Suppl 1","key":"4266_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/ard.2010.140582","volume":"70","author":"PJ Mease","year":"2011","unstructured":"Mease PJ (2011) Psoriatic arthritis: update on pathophysiology, assessment and management. Ann Rheum Dis 70(Suppl 1):77\u201384","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4266_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.39480","volume":"68","author":"JA Singh","year":"2016","unstructured":"Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC et al (2016) 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 68(1):1\u201326","journal-title":"Arthritis Rheumatol"},{"key":"4266_CR5","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1365-2133.1968.tb11947.x","volume":"80","author":"H Baker","year":"1968","unstructured":"Baker H, Ryan TJ (1968) Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases. Br J Dermatol 80:771\u2013793","journal-title":"Br J Dermatol"},{"issue":"8","key":"4266_CR6","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1111\/j.1468-3083.2012.04656.x","volume":"27","author":"U Mrowietz","year":"2013","unstructured":"Mrowietz U, Domm S (2013) Systemic steroids in the treatment of psoriasis: what is fact, what is fiction? J Eur Acad Dermatol Venereol 27(8):1022\u20131025. https:\/\/doi.org\/10.1111\/j.1468-3083.2012.04656.x","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"4266_CR7","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1002\/art.20335","volume":"50","author":"PJ Mease","year":"2004","unstructured":"Mease PJ, Kivitz AJ, Burch FX, Siegel EL, Cohen SB, Ory P, Salonen D, Rubenstein J, Sharp JT, Tsuji W (2004) Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression. Arthritis Rheum 50(7):2264\u20132272","journal-title":"Arthritis Rheum"},{"issue":"8","key":"4266_CR8","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1136\/ard.2004.032268","volume":"64","author":"C Antoni","year":"2005","unstructured":"Antoni C, Krueger GG, de Vlam K, Birbara C, Beutler A, Guzzo C, Zhou B, Dooley LT, Kavanaugh A (2005) IMPACT 2 Trial Investigators. Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis 64(8):1150\u20131157","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"4266_CR9","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1002\/art.21306","volume":"52","author":"PJ Mease","year":"2005","unstructured":"Mease PJ, Gladman DD, Ritchlin CT, Ruderman EM, Steinfeld SD, Choy EH, Sharp JT, Ory PA, Perdok RJ, Weinberg MA (2005) Adalimumab Effectiveness in Psoriatic Arthritis Trial Study Group. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 52(10):3279\u20133289","journal-title":"Arthritis Rheum"},{"issue":"8","key":"4266_CR10","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1002\/art.34436","volume":"64","author":"A Kavanaugh","year":"2012","unstructured":"Kavanaugh A, van der Heijde D, McInnes IB, Mease P, Krueger GG, Gladman DD, G\u00f3mez-Reino J, Papp K, Baratelle A, Xu W, Mudivarthy S, Mack M, Rahman MU, Xu Z, Zrubek J, Beutler A (2012) Golimumab in psoriatic arthritis: one-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial. Arthritis Rheum 64(8):2504\u20132517","journal-title":"Arthritis Rheum"},{"issue":"1","key":"4266_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/annrheumdis-2013-203696","volume":"73","author":"PJ Mease","year":"2014","unstructured":"Mease PJ, Fleischmann R, Deodhar AA, Wollenhaupt J, Khraishi M, Kielar D, Woltering F, Stach C, Hoepken B, Arledge T, van der Heijde D (2014) Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA). Ann Rheum Dis 73(1):48\u201355","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"4266_CR12","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1136\/annrheumdis-2013-204655","volume":"73","author":"C Ritchlin","year":"2014","unstructured":"Ritchlin C, Rahman P, Kavanaugh A, McInnes IB, Puig L, Li S, Wang Y, Shen YK, Doyle MK, Mendelsohn AM, Gottlieb AB (2014) PSUMMIT 2 Study Group. Efficacy and safety of the anti-IL-12\/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial. Ann Rheum Dis 73(6):990\u2013999","journal-title":"Ann Rheum Dis"},{"issue":"14","key":"4266_CR13","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1056\/NEJMoa1412679","volume":"373","author":"PJ Mease","year":"2015","unstructured":"Mease PJ, McInnes IB, Kirkham B, Kavanaugh A, Rahman P, van der Heijde D, Landew\u00e9 R, Nash P, Pricop L, Yuan J, Richards HB, Mpofu S (2015) FUTURE 1 Study Group. Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis. N Engl J Med 373(14):1329\u20131339","journal-title":"N Engl J Med"},{"issue":"4","key":"4266_CR14","first-page":"283","volume":"57","author":"C Cervini","year":"2005","unstructured":"Cervini C, Leardini G, Mathieu A, Punzi L, Scarpa R (2005) Psoriatic arthritis: epidemiological and clinical aspects in a cohort of 1.306 Italian patients. Reumatismo 57(4):283\u2013290","journal-title":"Reumatismo"},{"issue":"10","key":"4266_CR15","first-page":"833","volume":"9","author":"M Augustin","year":"2011","unstructured":"Augustin M, Schafer I, Reich K, Glaeske G, Radtke M (2011) Systemic treatment with corticosteroids in psoriasis\u2013health care provision far beyond the S3-guidelines. J Dtsch Dermatol Ges 9(10):833\u2013838","journal-title":"J Dtsch Dermatol Ges"},{"issue":"3","key":"4266_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2310\/7750.2013.13126","volume":"18","author":"A Al-Dabagh","year":"2014","unstructured":"Al-Dabagh A, Al-Dabagh R, Davis SA, Taheri A, Lin HC, Balkrishnan R, Feldman SR (2014) Systemic corticosteroids are frequently prescribed for psoriasis. J Cutan Med Surg 18(3):195\u2013199","journal-title":"J Cutan Med Surg"},{"key":"4266_CR17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/annrheumdis-2015-208337","volume":"75","author":"L Gossec","year":"2016","unstructured":"Gossec L, Smolen JS, Ramiro S, de Wit M, Cutolo M, Dougados M et al (2016) European league against rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis 75:499\u2013510","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4266_CR18","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.39573","volume":"68","author":"LC Coates","year":"2016","unstructured":"Coates LC, Kavanaugh A, Mease PJ, Soriano ER, Laura Acosta-Felquer M, Armstrong AW et al (2016) Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheumatol 68(5):1060\u20131071","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"4266_CR19","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/art.22489","volume":"56","author":"AM Turkiewicz","year":"2007","unstructured":"Turkiewicz AM, Moreland LW (2007) Psoriatic arthritis: current concepts on pathogenesis-oriented therapeutic options. Arthritis Rheum 56(4):1051\u20131066","journal-title":"Arthritis Rheum"},{"issue":"1","key":"4266_CR20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/bjd.14061","volume":"174","author":"LC Coates","year":"2016","unstructured":"Coates LC, Helliwell PS (2016) Psoriasis flare with corticosteroid use in psoriatic arthritis. Br J Dermatol 174(1):219\u2013221","journal-title":"Br J Dermatol"},{"key":"4266_CR21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/RHU.0b013e3182314d40","volume":"17","author":"F P\u00e9rez-Ruiz","year":"2011","unstructured":"P\u00e9rez-Ruiz F, Carmona L, Y\u00e9benes MJ, Pascual E, de Miguel E, Ure\u00f1a I et al (2011) GEMA Study Group, Sociedad Espa\u00f1ola de Reumatolog\u00eda. An audit of the variability of diagnosis and management of gout in the rheumatology setting: the gout evaluation and management study. J Clin Rheumatol 17:349\u2013355","journal-title":"J Clin Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04266-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-019-04266-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04266-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T05:54:14Z","timestamp":1721022854000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-019-04266-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["4266"],"URL":"https:\/\/doi.org\/10.1007\/s00296-019-04266-z","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,4]]},"assertion":[{"value":"28 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"In view of the fact that this paper is an anonymous, online survey not levelled at patients but at physicians, with the purpose of deriving opinions as to their prescribing pattern of glucocorticoids in patients with psoriatic arthritis, authorisation from the Bioethics Committee was not requested","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}